CDC - Outpatient Antibiotic Use and Prevalence of Antibiotic-Resistant Pneumococci in France and Germany: A Sociocultural Perspective

Volume 8, Number 12, December 2002

Outpatient Antibiotic Use and Prevalence of Antibiotic-Resistant Pneumococci in France and Germany: A Sociocultural Perspective

Stephan Harbarth,* Werner Albrich,† and Christian Brun-Buisson‡
*University of Geneva Hospitals, Geneva, Switzerland; †Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; and ‡University Hospital Henri Mondor, Créteil, France


	Back to article
	Figure 1. Summary of published aggregate data on the prevalence of pneumococci with intermediate (MIC >0.12 mg/L) and high-level (MIC >2.0 mg/L) resistance (A), and the prevalence of erythromycin-resistant pneumococci (B), France and Germany (3,6,7,9–11).

	EID Home \| Top of Page \| Ahead-of-Print \| Past Issues \| Suggested Citation \| EID Search \| Contact Us \| Accessibility \| Privacy Policy Notice \| CDC Home \| CDC Search \| Health Topics A-Z

	This page last reviewed March 21, 2003

	Emerging Infectious Diseases Journal National Center for Infectious Diseases Centers for Disease Control and Prevention